Solis BioDyne is a global biotech company based in Estonia and a world leader in the development of room-temperature stable reagents and enzymes. With over 27 years of experience in industrial-scale protein design and production, we offer flexibility and time-to-market leverage to create customized products and solutions, ranging from technical support to assay optimization. Our high standards have established Solis BioDyne as a trusted trademark worldwide, serving customers in over 110 countries.

Goodpoint Chemicals started business in 2009. We design, develope and produce high-quality and user-friendly products for medical and veterinary institutions with a wide efficacy spectrum, that have been tested in accredited laboratories. We listen carefully to our clients throughout product development and take account their input and wishes. Over 15 of our products are CE-certified. We are proud of our long-time partnerships with companies such as Lonza Corporation, BASF Corporation Chemicals Division, Brill&Partner GmBH, Robert Koch Institute, Eurofins and University of Bonn. Our latest products are the wound irrigaton solution Globasept®Wound Sol. and highly demanded chlorhexidine-based disinfectants.

• Over the course of 20 years as the leading hygiene expert in the Baltic States, we have developed, produced and distributed disinfectant, cleaning and skincare products for professional use in the medical sector.
• Our R&D is carried out by the in-house laboratory in cooperation with leading European researchers and universities. Through our in-depth research, we have developed a complete product line of an effective and minimally allergenic products for professional use.
• All Chemi-Pharm products meet the high standards of the very demanding medical sector and company’s operating and manufacturing processes are in compliance with ISO standards.
• Furthermore, our innovative product BioBlock® Nasal Spray with Antibodies against SARS-CoV-2, was invented in collaboration with Estonian Universities and other science driven companies.

• We help hospitals digitalization challenges by providing tailor-made software development services.
• Helmes is a digital innovation partner with 30+ years of experience. Companies Kuehne-Nagel, the OECD etc trust us to create their most complex business-critical software systems around the world.
• We have also created ca 30% of e-Estonia: digital prescriptions, e-elections, etc. Our unique methods quarantee world-class service and at least +150% efficiency compared to alternative partners.

• Aquator designs and manufactures professional medical equipment for hydrotherapy and balneotherapy. With a 20-year legacy of reliability and durability, Aquator has earned a reputition as a trustworthy partner, with a product range known for its longevity and user-friendliness.
• We use the latest technology to significantly improve medical procedural efficiency.
• Our products include hydro- and balneotherapeutic baths, tables for wrap procedures and mud therapy, baths for extremities, devices for underwater vacuum and shower massages.
• Our partners include research centres, clinics and rehabilitation centres, health resorts and spas.

• We are fast a growing manufactory.
• Our production is environmental friendly. Production processes are improved every year and the number of satisfied customers is growing.

Nanordica Medical has developed  an Advanced Wound Dressing  that prevents wound infection and promotes  wound healing. Nanordica Medical has demonstrated that the  wound dressing removes bacterial infection 8x better than the current best. Our value propositions are high efficacy and low cost. Our business model is B2B using distributors to reach our customers in hospitals, outpatient clinics, and pharmacies. Nanordica Medical has a priority for intellectual property and has completed a pilot clinical trial at the largest Estonian hospital. The data from clinical trial showed wound closure 2 times faster than the market leader. Our mission is to bring the product to the market to improve the outcome of wound infections, lower healthcare costs, and help hundreds of millions of patients. Nanordica Medical is open for co-development projects and commercial partnerships in veterinary medicine.

• Filtration and humidification of mechanically ventilated as well as spontaneously breathing patients.
• Bacterial/Viral filters protecting all patients and their health care staff such as anesthesiologists, ICU care takers, peditricians as well as all equipment included from potential risk of cross-contamination.
• Heat and moisture exchanger (HME) provides humidity for the patient’s airway in a most natural way. Small HME/filter type device placed in the breathing circuits that captures the heat and moisture exhaled from the patient’s own breath. “A natural way to keep patient’s airways protected and in the best condition”
• Known and valued over 30 years in more than 60 countries all over the world.

MERIANTO (est. 2004) IS A DESIGNER AND MANUFACTURER OF SPECIAL PURPOSE (INCL. HOSPITAL) FURNITURE WITH MANY YEARS OF EXPERIENCE.
Since its inception, Merianto Medical has the intention of providing interior solutions to healthcare institutions – considering their high standards and special needs. Merianto’s widespread experience with special solutions and quality client relationships support Merianto Medical’s creation of truly contemporary hospital solutions. Long-term experience in specialty furniture and the creation of complex interior solutions aid in creating a unique and complete solution for the client’s hospital environment.
OUR PARTNERS INCLUDE ALMOST ALL LARGEST HOSPITALS IN FINLAND AND ESTONIA, MAJOR CONSTRUCTION COMPANIES, HEALTH CENTERS, ELDERLY HOMES.

Migrevention is a an Estonian health technology company and Estonia’s first software based medical device manufacturer. Migrevention is a fully digital headache clinic and we offer digital solutions for patients, specialists and clinics to monitor, diagnose and treat migraine and other primary headaches. Migrevention’s mission is raising awareness and providing more accessible treatment to over 1.4B migraine patients in the world through digital therapeutics. At the moment, only 1-4% of migraine patients get evidence-based treatment, and the vast majority stays undiagnosed and untreated. Without sufficient treatment, the medical costs add up to 155 billion € per year only in the EU; and risks for migraine chronification, secondary health problems, and medication overuse headache rise drastically.